凌昌全教授治疗肝癌用药分析

《凌昌全教授治疗肝癌用药分析》由会员上传分享，免费在线阅读，更多相关内容在应用文档-天天文库。

1、从本学科出发，应着重选对国民经济具有一定实用价值和理论意义的课题。课题具有先进性，便于研究生提出新见解，特别是博士生必须有创新性的成果凌昌全教授治疗肝癌用药分析【摘要】　　在建立门诊肝癌专病病历的基础上，收集经凌昌全教授诊治的552例肝癌患者合计020张门诊有效处方，使用频数法总结凌教授的临床常用药物及其性味归经。运用logistic回归方法分析其辨证用药特点，聚类分析归纳其临床常用对药，结合专家体会对数据结果进行分析。凌教授治疗肝癌临床常用药物以健脾开胃、解毒抗癌和活血化瘀类为主，药性多平、凉，药味主以甘、苦、辛。气虚多选用黄芪、白术、太子参；血虚多用鸡血藤、大枣；阴虚多选用山茱萸、麦门冬

2、；水湿多用藿香、车前子、茯苓皮；实热多选用山栀、黄芩；血瘀多选用桃仁、赤芍；气滞多用郁金、八月札、柴胡。聚类分析共总结出19对临床常用对药。【关键词】凌昌全;肝癌;数学分析,统计;名医经验Abstract:Onthebasisofoutpatients'medicalrecordsconcerningprimarylivercancer(PLC),dataof5patients(with020effectiveprescriptions)fromtheOutpatientDepartmentofChanghaiHospitaltreatedbyProfessorLingChangquanwe

3、recollected.Thenature,flavorandmeridiandistributionoftheherbsusedintheprescriptionsweresummarizedbyfrequencymethod,课题份量和难易程度要恰当，博士生能在二年内作出结果，硕士生能在一年内作出结果，特别是对实验条件等要有恰当的估计。从本学科出发，应着重选对国民经济具有一定实用价值和理论意义的课题。课题具有先进性，便于研究生提出新见解，特别是博士生必须有创新性的成果andthefeaturesoftheherbsusedaccordingtosyndromedifferentiatio

4、nwereanalyzedbylogisticregression.Thecoupleherbsusedwereanalyzedbyclusteranalysis.Allthedatawereanalyzedincombinationwiththeexperienceofthespecialist.Itshowedthatmostofthefrequentlyusedherbswereherbsforinvigoratingthespleentopromoteappetite,removingtoxicmaterialstoinhibittumorgrowth,andactivatingbl

5、oodcirculationtodissipatebloodstasis.Theseherbsaremostlyofplainorcoolnature,andmainlyofsweet,bitter,oracridtaste.ItalsoshowedthatthemostfrequentlyusedherbsforqideficiencywereAstragalusmembranaceus,Atractylodesmacrocephala,andPseudostellariae;CaulisSpatholobiandChinesejujubeforbloodasthenia;FructusC

6、orniandOphiopogonjaponicusforyindeficiency;Agastacherugosa,SemenPlantaginisandPoriaforwaterdampness;capejasminefruitandbaikalskullcaprootforheatexcess;peachseedandRadixPaeoniaeRubraforbloodstasis;Curcumawenyujin,AkebiatrifoliataandBupleurumchinenseforqistagnation.Atotalof1pairsofcoupleherbsweresum

7、marizedbytheclusteranalysis.课题份量和难易程度要恰当，博士生能在二年内作出结果，硕士生能在一年内作出结果，特别是对实验条件等要有恰当的估计。从本学科出发，应着重选对国民经济具有一定实用价值和理论意义的课题。课题具有先进性，便于研究生提出新见解，特别是博士生必须有创新性的成果Keywords:LingChangquan;livercancer;dataanalysis,statist